Ocular Therapeutix, Inc.OCULNASDAQ

Revenue (LTM)

$52M

-18.7% YoY

Net Income (LTM)

$-266M

-37.4% YoY

Free Cash Flow

$-217M

Revenue CAGR (5Y)

+4.5%

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	44	51↑18.3%	58↑13.5%	64↑9.0%	52↓18.7%
Gross Profit	39	47↑20.0%	53↑13.2%	58↑9.3%	45↓22.1%
Operating Income	-78	-79↓0.8%	-82↓4.7%	-172↓108.5%	-270↓57.2%
Net Income	-7	-71↓984.1%	-81↓13.7%	-194↓139.7%	-266↓37.4%
EBITDA	3	-62↓2538.2%	-66↓7.3%	-176↓165.2%	-250↓41.8%
EPS Diluted	-0.98	-0.97↑1.0%	-1.02↓5.2%	-1.22↓19.6%	-1.42↓16.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	164	102↓37.7%	196↑91.4%	392↑100.2%	737↑88.0%
Total Current Assets	191	130↓32.2%	232↑79.2%	441↑89.9%	782↑77.4%
Total Assets	205	149↓27.1%	252↑68.8%	458↑81.7%	808↑76.5%
Total Current Liabilities	26	31↑19.2%	35↑11.2%	41↑18.5%	51↑22.9%
Total Liabilities	117	114↓2.5%	161↑41.3%	143↓11.4%	154↑7.8%
Total Equity	88	35↓59.8%	91↑157.6%	315↑246.0%	654↑107.5%
Total Debt	59	64↑9.0%	83↑29.7%	76↓9.1%	80↑5.3%
Net Debt	-105	-38↑63.9%	-112↓195.7%	-316↓181.4%	-657↓107.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-66	-60↑9.1%	-70↓17.8%	-135↓91.8%	-205↓52.1%
Capital Expenditure	-1	-4↓211.1%	-6↓63.8%	-1↑78.8%	-12↓832.5%
Free Cash Flow	-67	-63↑5.1%	-76↓20.5%	-136↓78.1%	-217↓59.5%
Stock-Based Comp	15	17↑13.3%	18↑5.1%	33↑85.7%	43↑30.4%
Net Change in Cash	-64	-62↑3.2%	94↑251.1%	196↑109.8%	345↑75.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance